Blue Earth Diagnostics
Click on an area of the booth to explore.
About Blue Earth Diagnostics
Blue Earth Diagnostics, a subsidiary of Bracco Imaging, is a recognized leader in the development and commercialization of novel PET radiopharmaceuticals to inform clinical management for cancer patients. Its portfolio includes a commercial product for recurrent prostate cancer and a robust pipeline of investigational agents. For more information, visit: www.blueearthdiagnostics.com